AAAAAA
Results: 1-25/53
Authors:
MESSORI A
TRIPPOLI S
Citation: A. Messori et S. Trippoli, COMMENT - COST-EFFECTIVE PHARMACEUTICAL CARE FOR HIV DISEASE - REPLY, The Annals of pharmacotherapy, 32(6), 1998, pp. 716-717
Authors:
TRIPPOLI S
MESSORI A
BECAGLI P
ALTERINI R
TENDI E
Citation: S. Trippoli et al., TREATMENTS FOR NEWLY-DIAGNOSED MULTIPLE-MYELOMA - ANALYSIS OF SURVIVAL-DATA AND COST-EFFECTIVENESS EVALUATION, Oncology Reports, 5(6), 1998, pp. 1475-1482
Authors:
MESSORI A
TRIPPOLI S
BECAGLI P
TENDI E
Citation: A. Messori et al., TREATMENTS FOR NEWLY-DIAGNOSED ADVANCED OVARIAN-CANCER - ANALYSIS OF SURVIVAL-DATA AND COST-EFFECTIVENESS EVALUATION, Anti-cancer drugs, 9(6), 1998, pp. 491-502
Authors:
MESSORI A
Citation: A. Messori, COST-EFFECTIVENESS OF INTERFERON IN CHRONIC MYELOID-LEUKEMIA - ANALYSIS OF 4 CLINICAL-STUDIES, Annals of oncology, 9(4), 1998, pp. 389-396
Authors:
BONISTALLI L
BARDELLI F
COSTANTINI M
TRALLORI G
DALBASIO G
MESSORI A
Citation: L. Bonistalli et al., ADJUVANT CHEMOTHERAPY IN PATIENTS WITH RESECTABLE STAGE-III COLON-CANCER - LIFETIME COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS, The Cancer journal, 11(1), 1998, pp. 39-47
Authors:
MESSORI A
COSTANTINI M
BONISTALLI L
ALTERINI R
Citation: A. Messori et al., 2ND BONE-MARROW TRANSPLANTATION IN NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 16(2), 1998, pp. 804-806
Authors:
MESSORI A
TRIPPOLI S
Citation: A. Messori et S. Trippoli, CAN THE Q-TWIST METHOD PROVIDE INFORMATION ON PATIENTS PREFERENCES WITHOUT COLLECTING PREFERENCE DATA FROM THE PATIENTS, Journal of clinical oncology, 16(11), 1998, pp. 3716-3717
Authors:
BOSI A
BACCI S
LASZLO D
LOCATELLI F
MESSORI A
VANLINT MT
DIBARTOLOMEO P
AMICI A
Citation: A. Bosi et al., COST-EFFECTIVENESS OF 2ND ALLOGENEIC BONE-MARROW TRANSPLANTATION (2BMT) IN PATIENTS WITH ACUTE-LEUKEMIA (AL), Bone marrow transplantation, 21, 1998, pp. 14-14
Authors:
MESSORI A
TRIPPOLI S
BECAGLI P
CINCOTTA M
LABBATE MG
ZACCARA G
Citation: A. Messori et al., ADJUNCTIVE LAMOTRIGINE THERAPY IN PATIENTS WITH REFRACTORY SEIZURES -A LIFETIME COST-UTILITY ANALYSIS, European Journal of Clinical Pharmacology, 53(6), 1998, pp. 421-427
Authors:
TRIPPOLI S
BECAGLI P
MESSORI A
TENDI E
Citation: S. Trippoli et al., MAINTENANCE TREATMENT WITH INTERFERON IN MULTIPLE-MYELOMA - A SURVIVAL METAANALYSIS, Clinical drug investigation, 14(5), 1997, pp. 392-399
Authors:
TRALLORI G
MESSORI A
Citation: G. Trallori et A. Messori, DRUG TREATMENTS FOR MAINTAINING REMISSION IN CROHNS-DISEASE - A LIFETIME COST-UTILITY ANALYSIS, PharmacoEconomics, 11(5), 1997, pp. 444-453
Authors:
MESSORI A
BECAGLI P
BERTO V
TRIPPOLI S
FONT M
TOSOLINI F
VENTURINI F
MARTINI N
Citation: A. Messori et al., ADVANCED HIV-INFECTION TREATED WITH ZIDOVUDINE MONOTHERAPY - LIFETIMEVALUES OF ABSOLUTE COST-EFFECTIVENESS AS A PHARMACOECONOMIC REFERENCEFOR FUTURE STUDIES EVALUATING ANTIRETROVIRAL COMBINATION TREATMENTS, The Annals of pharmacotherapy, 31(12), 1997, pp. 1447-1454
Authors:
DAVINI I
BECAGLI P
PANI M
TRIPPOLI S
PEVERINI D
MESSORI A
CARMIGNANI A
Citation: I. Davini et al., COST-EFFECTIVENESS OF NEOADJUVANT MULTIMODAL THERAPY IN PATIENTS WITHESOPHAGEAL ADENOCARCINOMA, Oncology Reports, 4(5), 1997, pp. 1033-1037
Authors:
MESSORI A
BECAGLI P
TRIPPOLI S
TENDI E
Citation: A. Messori et al., A RETROSPECTIVE COST-EFFECTIVENESS ANALYSIS OF INTERFERON AS ADJUVANTTHERAPY IN HIGH-RISK RESECTED CUTANEOUS MELANOMA, European journal of cancer, 33(9), 1997, pp. 1373-1379
Authors:
MESSORI A
Citation: A. Messori, CURRENT CONTROVERSIES IN THE APPLICATION OF METAANALYSIS (WITH SPECIAL REFERENCE TO ONCOLOGICAL TREATMENTS), Pharmacy world & science, 19(3), 1997, pp. 152-158
Authors:
MESSORI A
BECAGLI P
TRIPPOLI S
Citation: A. Messori et al., MEDIAN VERSUS MEAN LIFETIME SURVIVAL IN THE ANALYSIS OF SURVIVAL-DATA, Haematologica, 82(6), 1997, pp. 730-730
Authors:
MESSORI A
BONISTALLI L
COSTANTINI M
ALTERINI R
Citation: A. Messori et al., COST-EFFECTIVENESS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 19(3), 1997, pp. 275-281
Authors:
MESSORI A
Citation: A. Messori, SURVIVAL-CURVE FITTING USING THE GOMPERTZ FUNCTION - A METHODOLOGY FOR CONDUCTING COST-EFFECTIVENESS ANALYSES ON MORTALITY DATA, Computer methods and programs in biomedicine, 52(3), 1997, pp. 157-164
Authors:
TRIPPOLI S
BECAGLI P
MESSORI A
Citation: S. Trippoli et al., ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE AND FLUOROURACIL FOR NODE-POSITIVE BREAST-CANCER - A LIFETIME COST-UTILITY ANALYSIS BASED ON A MODIFIED Q-TWIST METHOD, European Journal of Clinical Pharmacology, 53(3-4), 1997, pp. 281-282
Authors:
MESSORI A
BECAGLI P
TRIPPOLI S
TENDI E
Citation: A. Messori et al., COST-EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE PLUS METHOTREXATE PLUS FLUOROURACIL IN PATIENTS WITH NODE-POSITIVE BREAST-CANCER (VOL 51, PG 111, 1996), European Journal of Clinical Pharmacology, 51(5), 1997, pp. 427-427
Authors:
MESSORI A
CECCHI M
BECAGLI P
TRIPPOLI S
Citation: A. Messori et al., PHARMACOECONOMIC PROFILE OF PACLITAXEL AS A FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED OVARIAN-CARCINOMA - A LIFETIME COST-EFFECTIVENESS ANALYSIS, Cancer, 79(11), 1997, pp. 2264-2266
Authors:
FERRANDINA G
SCAMBIA G
BARDELLI F
PANICI PB
MANCUSO S
MESSORI A
Citation: G. Ferrandina et al., RELATIONSHIP BETWEEN CATHEPSIN-D CONTENT AND DISEASE-FREE SURVIVAL INNODE-NEGATIVE BREAST-CANCER PATIENTS - A METAANALYSIS, British Journal of Cancer, 76(5), 1997, pp. 661-666
Authors:
MESSORI A
BECAGLI P
TRIPPOLI S
Citation: A. Messori et al., COST-EFFECTIVENESS OF INTERFERON-ALPHA AS MAINTENANCE THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA, Annals of internal medicine, 126(8), 1997, pp. 664-664
Authors:
DALBASIO G
PACINI F
CAMARRI E
MESSORI A
TRALLORI G
BONANOMI AG
BARDAZZI G
MILLA M
FERRERO S
BIAGINI M
QUARANTA S
AMOROSI A
Citation: G. Dalbasio et al., COMBINED THERAPY WITH 5-AMINOSALICYLIC ACID TABLETS AND ENEMAS FOR MAINTAINING REMISSION IN ULCERATIVE-COLITIS - A RANDOMIZED DOUBLE-BLIND-STUDY, The American journal of gastroenterology, 92(7), 1997, pp. 1143-1147
Authors:
CRUCIANI M
RAMPAZZO R
MALENA M
LAZZARINI L
TODESCHINI G
MESSORI A
CONCIA E
Citation: M. Cruciani et al., PROPHYLAXIS WITH FLUOROQUINOLONES FOR BACTERIAL-INFECTIONS IN NEUTROPENIC PATIENTS - A METAANALYSIS, Clinical infectious diseases, 23(4), 1996, pp. 795-805